Impact of Nischarin on EMT regulators in breast cancer cell lines

Yuan‐Jie Cai, Bo Ma, Meili Wang, Jie Chen, Fuguang Zhao, Juandi Zhou, Xu Guo, Lei Zheng, Chunjing Xu, Yi Wang, Yibo He, Jian Liu, Shangnao XieOncology 2020 · DOI

Abstract

Nischarin is an integrin-binding protein known as a novel tumor suppressor. In breast cancer, Nischarin plays a critical role in cell migration and invasion. However, the molecular mechanism underlying its role remains unclear. Recent findings suggest that the epithelial-mesenchymal transition (EMT) increases cell migration and invasion capacity. This study hypothesized that Nischarin regulates cellular processes via signaling pathways associated with the EMT process. By detecting mRNA and protein levels of EMT regulators following NISCH-overexpression and knockdown, the results demonstrated that Nischarin inhibits cell proliferation, migration, and invasion. Specifically, NISCH overexpression increased E-cadherin levels while decreasing transcription factors like Snail, ZEB1, N-cadherin, Slug, Twist1, and vimentin. These effects were reversed upon NISCH silencing, indicating that Nischarin suppresses metastasis by inhibiting the EMT process.

Introduction

Metastasis is the primary cause of mortality in breast cancer patients. A pivotal step in this progression is the Epithelial-Mesenchymal Transition (EMT), where stationary epithelial cells transform into mobile, invasive mesenchymal cells. While Nischarin was previously identified as a tumor suppressor, its specific influence on the genetic regulators of EMT, particularly in aggressive triple-negative breast cancer (TNBC) subtypes, required further elucidation.

Experimental Validation

To investigate these mechanisms, researchers utilized two human TNBC cell lines: Hs578T (characterized by low endogenous Nischarin) and MDA-MB-231 (higher endogenous Nischarin). They employed a "push-pull" experimental design to observe the effects of varying Nischarin levels.

Validation of Nischarin overexpression in Hs578T cells and knockdown in MDA-MB-231 cells via Western blot and quantitative analysis.

As shown in the figure above, Nischarin levels were successfully boosted in Hs578T cells using a pcDNA3.1-Nischarin plasmid (overexpression) and significantly reduced in MDA-MB-231 cells using small interfering RNA (siRNA) knockdown. These manipulations provided the foundation for measuring changes in EMT markers.

Key Insights: Nischarin as a Master Regulator

The study's most significant finding is that Nischarin acts as a master regulator of the EMT network. It does not merely affect a single marker but influences a suite of EMT-inducing transcription factors, including Snail, ZEB1, Slug, and Twist1.

  • Restoration of Epithelial Characteristics: Overexpression of Nischarin leads to an increase in E-cadherin, the protein responsible for cell-to-cell adhesion, effectively "gluing" cells in place.
  • Suppression of Mesenchymal Markers: Simultaneously, Nischarin suppresses mesenchymal markers such as Vimentin and N-cadherin, which are associated with increased motility and invasiveness.
  • Anti-Metastatic Focus: Interestingly, while Nischarin significantly inhibited migration and invasion in functional assays, its impact on short-term cell proliferation was minimal. This suggests its primary therapeutic potential lies in preventing metastasis rather than just reducing primary tumor growth.

Conclusion and Future Directions

The results confirm that Nischarin suppresses cell migration and invasion by inhibiting the EMT process. However, some limitations remain. While mRNA changes were consistent across all seven tested EMT markers, protein-level confirmation was only achieved for Twist1, Slug, and Vimentin. Furthermore, the specific signaling pathways (such as TGF-β or Wnt) through which Nischarin exerts these effects are yet to be mapped. Future research involving in vivo animal models is necessary to validate these findings within a complex biological environment.

Summary updated

Abstract

Nischarin is an integrin-binding protein, which is well known as a novel tumor suppressor. In breast cancer, Nischarin serves a critical role in breast cancer cell migration and invasion. However, the molecular mechanism underlying the role of Nischarin remains unclear. Recent findings have demonstrated that epithelial-mesenchymal transition (EMT) increases the capacity of cell migration and invasion. As a member of the integrin family, it was hypothesized that Nischarin may regulate cellular processes via various signaling pathways associated with the EMT process. The present study detected the mRNA levels of EMT regulators via reverse transcription-quantitative PCR and related protein levels via western blotting in breast cancer cells, following <i>NISCH</i>-overexpression and -knockdown. The results demonstrated that Nischarin inhibits cell proliferation, migration and invasion in breast cancer cells. Furthermore, when the <i>NISCH</i> gene was overexpressed, the relative mRNA level of E-cadherin was increased, while the relative mRNA levels of several transcription factors, such as Snail, ZEB1, N-cadherin, Slug, Twist1 and vimentin, decreased. When NISCH was silenced, these results were reversed. The present results demonstrated that Nischarin suppresses cell migration and invasion via inhibiting the EMT process.
BibTeX
@inproceedings{cai2020impact,
  author = {Yuan‐Jie Cai and Bo Ma and Meili Wang and Jie Chen and Fuguang Zhao and Juandi Zhou and Xu Guo and Lei Zheng and Chunjing Xu and Yi Wang and Yibo He and Jian Liu and Shangnao Xie},
  title = {{Impact of Nischarin on EMT regulators in breast cancer cell lines}},
  booktitle = {Oncology},
  year = {2020},
  doi = {10.3892/ol.2020.12154},
}
Figure